Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amplification”

304 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 304 results

Testing effectiveness (Phase 2)UnknownNCT05135715
What this trial is testing

RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

Who this might be right for
Melanoma, Stage IIHER2-positiveAdvanced Melanoma
RemeGen Co., Ltd. 50
Testing effectiveness (Phase 2)WithdrawnNCT05041972
What this trial is testing

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

Who this might be right for
HER2 Mutation-Related TumorsHER2 Amplified Solid Tumors
Ambrx, Inc.
Testing effectiveness (Phase 2)UnknownNCT04136600
What this trial is testing

EGFR Monoclonal Antibody for Advanced Gastric Cancer

Who this might be right for
Gastric CancerCetuximabNimotuzumab
Shanghai Changzheng Hospital 100
Not applicableStudy completedNCT05653999
What this trial is testing

Assessing Speech Perception and Amplification Benefit During Infancy

Who this might be right for
Hearing LossChildren With Hearing DifferencesAmplification+1 more
University of Colorado, Denver 36
Testing effectiveness (Phase 2)Ended earlyNCT04718675
What this trial is testing

KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Who this might be right for
Relapsed Solid TumorsRefractory Solid TumorsNon-Hodgkin Lymphoma+2 more
Kronos Bio 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07080619
What this trial is testing

SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers

Who this might be right for
TNBC - Triple-Negative Breast CancerHR+ Breast Cancer
Tianjin ConjuStar Biologics Co., Ltd. 120
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Large-scale testing (Phase 3)Ended earlyNCT04816214
What this trial is testing

Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 6
Early research (Phase 1)Looking for participantsNCT06586957
What this trial is testing

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more
NiKang Therapeutics, Inc. 150
Testing effectiveness (Phase 2)WithdrawnNCT05567055
What this trial is testing

Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations

Who this might be right for
Non-small Cell Lung Cancer
Timothy Burns, MD, PHD
Not applicableStudy completedNCT01066507
What this trial is testing

Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections

Who this might be right for
Breast Cancer
Applied Spectral Imaging Ltd. 126
Not applicableUnknownNCT02002416
What this trial is testing

Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma

Who this might be right for
Gastric Cancer
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Study completedNCT00356811
What this trial is testing

Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 57
Not applicableStudy completedNCT02252198
What this trial is testing

Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests

Who this might be right for
Tuberculosis
Johns Hopkins University 504
Not applicableLooking for participantsNCT07533799
What this trial is testing

The Swedish BioFINDER Sleep Study

Who this might be right for
Parkinson´s DiseaseREM Sleep Behavior Disorder (iRBD)Lewy Body Disease+2 more
Skane University Hospital 650
Not applicableUnknownNCT02502214
What this trial is testing

Feasibility Study of Preimplantation Genetic Diagnosis for Single-gene Disorders

Who this might be right for
Preimplantation Diagnosis
University Hospital, Strasbourg, France 30
Early research (Phase 1)Study completedNCT01472016
What this trial is testing

Study of ABT-700 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie (prior sponsor, Abbott) 74
Not applicableStudy completedNCT03444168
What this trial is testing

Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome

Who this might be right for
Chronic Pain
University of Kansas Medical Center 158
Not applicableEnded earlyNCT05052372
What this trial is testing

Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Who this might be right for
Bladder CancerUrothelial CarcinomaTransitional Cell Carcinoma+10 more
xCures 2
Testing effectiveness (Phase 2)Study completedNCT02414139
What this trial is testing

Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 373
Load More Results